GlassScriptPhysician profile
Ariel B Paskin
NPI 1518114248
$4,770.72
in general payments reported to CMS, 2019-2025
34 companies · $804 in 2025
The $804 reported for 2025 was more than what 94% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.91 · 2022: $1,580 · 2023: $1,485 · 2024: $886 · 2025: $804.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,173.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,609.74 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $428.22 | 2023-2025 | Myfembree |
| Pfizer INC. | $270.77 | 2022-2025 | |
| Corium, LLC | $234.15 | 2022-2024 | Azstarys |
| Mayne Pharma Commercial LLC | $204.79 | 2022-2025 | |
| Exeltis, USA INC. | $185.45 | 2022-2025 | Slynd |
| Scynexis, INC. | $183.86 | 2022 | |
| Astellas Pharma US INC | $176.48 | 2022-2025 | Veozah |
| Myovant Sciences INC. | $159.77 | 2022 | |
| Coopersurgical, INC. | $147.28 | 2022-2025 | Paragard T 380a, Paragard T 380a, Mara Console |
| Evofem Biosciences, INC. | $110.74 | 2022-2024 | Phexxi |
| Sage Therapeutics, LLC | $92.12 | 2025 | Zurzuvae |
| Organon LLC | $89.65 | 2022-2024 | Nexplanon |
| Exact Sciences Corporation | $87.42 | 2023-2025 | Cologuard Collection Kit |
| Bausch Health US, LLC | $85.97 | 2021-2025 | Wellbutrin |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $74.93 | 2023-2024 | Perclot, Adept |
| Takeda Pharmaceuticals U.S.A., INC. | $70.37 | 2022-2024 | Trintellix |
| Biohaven Pharmaceutical Holding Company LTD. | $69.55 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $67.93 | 2022-2024 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $56.71 | 2025 | Caplyta |
| Daiichi Sankyo INC. | $49.68 | 2024 | Injectafer |
| Lilly USA, LLC | $47.53 | 2022-2025 | Emgality, Zepbound |
| Hologic Sales and Service, LLC | $42.29 | 2023-2025 | Aptima, Thinprep 2000 Processor |
| Biogen, INC. | $28.10 | 2022 | |
| Alkermes, INC. | $27.72 | 2023 | Aristada, Lybalvi |
| Agile Therapeutics, INC. | $24.85 | 2023 | Twirla |
| Amgen INC. | $21.40 | 2025 | Evenity |
| Avion Pharmaceuticals | $21.04 | 2023 | Balcoltra |
| Ibsa Pharma INC. | $20.39 | 2023 | Tirosint, Licart |
| Aspira Women'S Health INC | $19.92 | 2024 | Ova1 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.90 | 2024 | Xifaxan |
| Channel Medsystems, INC. | $16.98 | 2023-2024 | |
| Millicent US INC | $13.46 | 2023 | Intrarosa, Femring |
| Mylan Pharmaceuticals INC. | $12.56 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ariel Paskin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.